003060.KS · 에이프로젠바이오로직스
South Korea · RS rating 58 · As of 2026-10-14
| Price | 1,489.00 KRW |
|---|---|
| 1-day change | +0.7% |
| RS rating (overall / 1M / 3M / 12M) | 58 / 21 / 7 / 94 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 29 / 50 / 23 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | -233.2% |
| Sales growth Q/Q | +6.8% |
| Distance from 52-week high | +70.8% |
| Market cap (USD) | $18.7M |